Other compounds that target the DNA binding domain of the MYC–MAX complex such as KSI-3716 [149], MYCi975 [150], sAJM589 [151], and 10074-G5 [152,153] were found to have anti-tumor effects in multiple tumor cell types. Here, MYC is linked to neoplasm.